Valuation: Avinger, Inc.

Market Cap 27.07L 23.74L 21.92L 20.26L 38.4L 26Cr 39.16L 2.64Cr 1.02Cr 13Cr 1.02Cr 99.43L 44Cr P/E 2022
-0.25x
P/E 2023 -0.19x
Enterprise Value 1.28Cr 1.13Cr 1.04Cr 95.98L 1.82Cr 122.82Cr 1.86Cr 12Cr 4.85Cr 60Cr 4.82Cr 4.71Cr 208.65Cr EV / Sales 2022
1.19x
EV / Sales 2023 1.78x
Free-Float
88.44%
Yield 2022 *
-
Yield 2023 -
Manager TitleAgeSince
Chief Executive Officer - -
Chief Tech/Sci/R&D Officer - 05/08/2024
Change 5-day change 1-year change 3-year change Capi.($)
-15.90%+1,100.00% - - 15.15L
+1.13%+1.05%-17.93%-27.15% 1.27TCr
+2.44%-5.91%+85.34%+14.55% 506.69Cr
+0.80%-4.66%+60.93%+102.78% 123.11Cr
-0.70%-3.75%-34.86%-63.94% 117.01Cr
+0.58%-1.51%-39.86%-48.19% 107.89Cr
-1.15%-3.70%-49.41% - 87Cr
-0.06%-5.55%+155.21%+143.31% 62Cr
-2.78%-17.99%+22.09% - 31Cr
+2.89%-2.51%-53.24%+227.74% 25Cr
Average -1.28%-5.11%+14.25%+49.87% 258.25Cr
Weighted average by Cap. +1.13%-1.11%+10.46%-5.64%

Financials

2022 2023
Net sales 82.73L 72.56L 66.99L 61.91L 1.17Cr 79Cr 1.2Cr 8.05Cr 3.13Cr 39Cr 3.11Cr 3.04Cr 134.57Cr 76.52L 67.12L 61.96L 57.26L 1.09Cr 73Cr 1.11Cr 7.45Cr 2.89Cr 36Cr 2.87Cr 2.81Cr 124.47Cr
Net income -1.76Cr -1.55Cr -1.43Cr -1.32Cr -2.5Cr -168.74Cr -2.55Cr -17Cr -6.67Cr -83Cr -6.62Cr -6.47Cr -286.66Cr -1.83Cr -1.61Cr -1.48Cr -1.37Cr -2.6Cr -175.42Cr -2.65Cr -18Cr -6.93Cr -86Cr -6.88Cr -6.73Cr -297.99Cr
Net Debt 17.56L 15.4L 14.22L 13.14L 24.91L 17Cr 25.4L 1.71Cr 66.42L 8.23Cr 65.94L 64.5L 29Cr 1.01Cr 88.76L 81.95L 75.73L 1.44Cr 97Cr 1.46Cr 9.85Cr 3.83Cr 47Cr 3.8Cr 3.72Cr 164.61Cr
Logo Avinger, Inc.
Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.
Employees
-